These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12427308)

  • 1. Dose-dependent neuroprotective effect of ciliary neurotrophic factor delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's disease.
    Régulier E; Pereira de Almeida L; Sommer B; Aebischer P; Déglon N
    Hum Gene Ther; 2002 Nov; 13(16):1981-90. PubMed ID: 12427308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington's disease.
    de Almeida LP; Zala D; Aebischer P; Déglon N
    Neurobiol Dis; 2001 Jun; 8(3):433-46. PubMed ID: 11442352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term lentiviral-mediated expression of ciliary neurotrophic factor in the striatum of Huntington's disease transgenic mice.
    Zala D; Bensadoun JC; Pereira de Almeida L; Leavitt BR; Gutekunst CA; Aebischer P; Hayden MR; Déglon N
    Exp Neurol; 2004 Jan; 185(1):26-35. PubMed ID: 14697316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease.
    Emerich DF; Winn SR; Hantraye PM; Peschanski M; Chen EY; Chu Y; McDermott P; Baetge EE; Kordower JH
    Nature; 1997 Mar; 386(6623):395-9. PubMed ID: 9121555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effects of encapsulated CNTF-producing cells in a rodent model of Huntington's disease are dependent on the proximity of the implant to the lesioned striatum.
    Emerich DF; Winn SR
    Cell Transplant; 2004; 13(3):253-9. PubMed ID: 15191163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular delivery of CNTF but not NT-4/5 prevents degeneration of striatal neurons in a rodent model of Huntington's disease.
    Emerich DF; Bruhn S; Chu Y; Kordower JH
    Cell Transplant; 1998; 7(2):213-25. PubMed ID: 9588602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease.
    Kells AP; Fong DM; Dragunow M; During MJ; Young D; Connor B
    Mol Ther; 2004 May; 9(5):682-8. PubMed ID: 15120329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular delivery of human CNTF prevents motor and cognitive dysfunction in a rodent model of Huntington's disease.
    Emerich DF; Cain CK; Greco C; Saydoff JA; Hu ZY; Liu H; Lindner MD
    Cell Transplant; 1997; 6(3):249-66. PubMed ID: 9171158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulated delivery of glial cell line-derived neurotrophic factor into rat striatum, using a tetracycline-dependent lentiviral vector.
    Georgievska B; Jakobsson J; Persson E; Ericson C; Kirik D; Lundberg C
    Hum Gene Ther; 2004 Oct; 15(10):934-44. PubMed ID: 15585109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinolinic acid lesions of the caudate putamen in the rat lead to a local increase of ciliary neurotrophic factor.
    Haas SJ; Ahrens A; Petrov S; Schmitt O; Wree A
    J Anat; 2004 Apr; 204(4):271-81. PubMed ID: 15061753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent neurochemical and functional protection afforded by encapsulated CNTF-producing cells.
    Emerich DF
    Cell Transplant; 2004; 13(7-8):839-44. PubMed ID: 15690987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington's disease.
    Mittoux V; Joseph JM; Conde F; Palfi S; Dautry C; Poyot T; Bloch J; Deglon N; Ouary S; Nimchinsky EA; Brouillet E; Hof PR; Peschanski M; Aebischer P; Hantraye P
    Hum Gene Ther; 2000 May; 11(8):1177-87. PubMed ID: 10834619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effect of interleukin-6 and IL6/IL6R chimera in the quinolinic acid rat model of Huntington's syndrome.
    Bensadoun JC; de Almeida LP; Dréano M; Aebischer P; Déglon N
    Eur J Neurosci; 2001 Dec; 14(11):1753-61. PubMed ID: 11860469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human neural stem cell transplants improve motor function in a rat model of Huntington's disease.
    McBride JL; Behrstock SP; Chen EY; Jakel RJ; Siegel I; Svendsen CN; Kordower JH
    J Comp Neurol; 2004 Jul; 475(2):211-9. PubMed ID: 15211462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentiviral delivery of meteorin protects striatal neurons against excitotoxicity and reverses motor deficits in the quinolinic acid rat model.
    Jørgensen JR; Emerich DF; Thanos C; Thompson LH; Torp M; Bintz B; Fjord-Larsen L; Johansen TE; Wahlberg LU
    Neurobiol Dis; 2011 Jan; 41(1):160-8. PubMed ID: 20840868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticostriatopallidal neuroprotection by adenovirus-mediated ciliary neurotrophic factor gene transfer in a rat model of progressive striatal degeneration.
    Mittoux V; Ouary S; Monville C; Lisovoski F; Poyot T; Conde F; Escartin C; Robichon R; Brouillet E; Peschanski M; Hantraye P
    J Neurosci; 2002 Jun; 22(11):4478-86. PubMed ID: 12040055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease.
    Hughes PE; Alexi T; Williams CE; Clark RG; Gluckman PD
    Neuroscience; 1999; 92(1):197-209. PubMed ID: 10392842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease.
    Alexi T; Hughes PE; van Roon-Mom WM; Faull RL; Williams CE; Clark RG; Gluckman PD
    Exp Neurol; 1999 Sep; 159(1):84-97. PubMed ID: 10486177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AAV-mediated delivery of ciliary neurotrophic factor prolongs photoreceptor survival in the rhodopsin knockout mouse.
    Liang FQ; Dejneka NS; Cohen DR; Krasnoperova NV; Lem J; Maguire AM; Dudus L; Fisher KJ; Bennett J
    Mol Ther; 2001 Feb; 3(2):241-8. PubMed ID: 11237681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study.
    Bloch J; Bachoud-Lévi AC; Déglon N; Lefaucheur JP; Winkel L; Palfi S; Nguyen JP; Bourdet C; Gaura V; Remy P; Brugières P; Boisse MF; Baudic S; Cesaro P; Hantraye P; Aebischer P; Peschanski M
    Hum Gene Ther; 2004 Oct; 15(10):968-75. PubMed ID: 15585112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.